This inventor holds 1 USPTO granted patent. Top assignee: Melio Healthcare Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eduardo Alves and Immune-System Phenotyping Innovation.
Introduction
Eduardo Alves is an inventor associated with London, Great Britain, and Melio Healthcare Limited. His patent work concerns standardized immune-system phenotyping and automated classification of immune cells.
Latest Patents
Alves is associated with 1 patent, titled “Systems and Methods for Comprehensive and Standardized Immune System Phenotyping and Automated Cell Classification.” The invention describes methods for generating an immune profile from a subject’s sample. Fluorescently labeled cells are analyzed using a full-spectrum flow cytometer, and an ensemble machine-learning model classifies individual cells into distinct immune-cell subpopulations. The system can then report a total cell count or frequency for each subpopulation as part of the subject’s immune profile.
Career Highlights
The patent reflects work at the intersection of flow cytometry, machine learning, and immune profiling. It aims to support comprehensive and standardized analysis by automating the classification and measurement of immune-cell populations.
Collaborations
Alves is associated with Melio Healthcare Limited. The provided information also names Jeremy Mason and Per Ullberg as coworkers.
Conclusion
Eduardo Alves’s patent describes an automated approach to immune profiling that combines full-spectrum flow cytometry with machine-learning-based cell classification.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile